Constellation Pharmaceuticals Inc (CNST) Stock Analyst Ratings
NASDAQ:CNST - Nasdaq -
ChartMill assigns a Buy % Consensus number of 71% to CNST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 41.53. This target is 22.18% above the current price.
CNST was analyzed by 7 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about CNST.
In the previous month the buy percentage consensus was at a similar level.
CNST was analyzed by 7 analysts. More opinions would make the average more meaningful.